Published in Med J Aust on April 03, 2000
Headache and face pain. Med J Aust (2000) 1.39
Hypovitaminosis D in female patients with chronic low back pain. Clin Rheumatol (2007) 1.20
A comparison of outcomes in osteoarthritis patients undergoing total hip and knee replacement surgery. Osteoarthritis Cartilage (2001) 2.54
Outcomes after hip or knee replacement surgery for osteoarthritis. A prospective cohort study comparing patients' quality of life before and after surgery with age-related population norms. Med J Aust (1999) 2.28
Does colchicine work? The results of the first controlled study in acute gout. Aust N Z J Med (1987) 2.17
Risk taking in patients with rheumatoid arthritis: are the risks of haemopoietic stem cell transplantation acceptable? Rheumatology (Oxford) (1999) 2.09
Preventing acute gout when starting allopurinol therapy. Colchicine or NSAIDs? Med J Aust (1993) 2.09
The patient is the teacher: ambulatory patient-centred student-based interprofessional education where the patient is the teacher who improves patient care outcomes. Intern Med J (2013) 2.03
A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario. J Rheumatol (1988) 1.71
Copper-salicylate gel for pain relief in osteoarthritis: a randomised controlled trial. Med J Aust (1997) 1.66
The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. I. Clinical effects. J Rheumatol (1988) 1.60
Serum immunoreactive gastrin: specificity for rheumatoid arthritis, bimodality of distribution, and failure of effect of anti-inflammatory drugs. Ann Rheum Dis (1976) 1.42
The cycling of combination antirheumatic drug therapy in rheumatoid arthritis. Br J Rheumatol (1990) 1.41
Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet (1985) 1.39
Is diet important in rheumatoid arthritis? Br J Rheumatol (1991) 1.39
Methotrexate in rheumatoid arthritis. Aust N Z J Med (1988) 1.38
Teaching residents about complementary and alternative medicine in the United States. J Gen Intern Med (1998) 1.38
Antirheumatic medication during lactation. Br J Rheumatol (1985) 1.33
Septic arthritis in patients with rheumatoid disease: a still underdiagnosed complication. J Rheumatol (1976) 1.31
Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. J Rheumatol (1985) 1.29
Patient self-efficacy and health locus of control: relationships with health status and arthritis-related expenditure. Rheumatology (Oxford) (2005) 1.25
Plasma aspirin esterases in normal individuals, patients with alcoholic liver disease and rheumatoid arthritis: characterization and the importance of the enzymic components. Eur J Clin Invest (1980) 1.25
Living with rheumatoid arthritis: expenditures, health status, and social impact on patients. Ann Rheum Dis (2002) 1.23
Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis. Clin Pharmacokinet (1982) 1.19
How safe are anti-rheumatic drugs? A study of possible iatrogenic deaths in patients with rheumatoid arthritis. Health Bull (Edinb) (1975) 1.19
Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes. Clin Exp Immunol (1991) 1.17
Assessment of nonsteroidal anti-inflammatory drug combinations by the polyurethane sponge implantation model in the rat. Ann Rheum Dis (1983) 1.13
Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol (1993) 1.11
Haemopoietic stem cell transplantation for autoimmune diseases. Br J Haematol (1997) 1.11
Lymphocyte subsets and inflammatory indices in synovial fluid and blood of patients with rheumatoid arthritis. J Rheumatol (1984) 1.10
Binding of haptoglobin, inter-alpha-trypsin inhibitor, and alpha 1 proteinase inhibitor to synovial fluid hyaluronate and the influence of these proteins on its degradation by oxygen derived free radicals. Ann Rheum Dis (1988) 1.08
Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients. Rheumatol Int (1988) 1.08
Treatment outcome of major fractures of the talus. Foot Ankle Int (1995) 1.08
NSAID and osteoarthritis--help or hindrance? J Rheumatol (1982) 1.07
Chinese herbal arthritis cure and agranulocytosis. Med J Aust (1978) 1.07
Two knees or not two knees? Patient costs and outcomes following bilateral and unilateral total knee joint replacement surgery for OA. Osteoarthritis Cartilage (2004) 1.04
Indomethacin--aspirin interaction: a clinical appraisal. Br Med J (1975) 1.04
Articular chondrocalcinosis in a hospital population: an Australian experience. Aust N Z J Med (1984) 1.04
Determinants of willingness to pay for hip and knee joint replacement surgery for osteoarthritis. Rheumatology (Oxford) (2000) 1.04
A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit. Br J Pharmacol (1985) 1.04
Interleukin-1 secretion by peripheral blood monocytes and synovial macrophages from patients with rheumatoid arthritis. J Rheumatol (1987) 1.04
Determinants of disability in rheumatoid arthritis. Br J Rheumatol (1988) 1.03
Alterations in prednisolone disposition as a result of time of administration, gender and dose. Br J Clin Pharmacol (1984) 1.01
Methylprednisolone infusion therapy in rheumatoid arthritis patients. The effect on synovial fluid lymphocyte subsets and inflammatory indices. Arthritis Rheum (1986) 1.00
Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha. Clin Exp Immunol (1990) 0.99
Variations in response to non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol (1987) 0.99
Comparison of methylprednisolone (1 g i.v.) with prednisolone (1 g orally) in rheumatoid arthritis: a pharmacokinetic and clinical study. J Rheumatol (1988) 0.98
Structural requirements for drug binding to site II on human serum albumin. Mol Pharmacol (1983) 0.98
The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. II. Effects on immune and inflammatory indices in peripheral blood. J Rheumatol (1988) 0.98
The subcutaneous air pouch model of synovium and the inflammatory response to heat aggregated gammaglobulin. Agents Actions (1986) 0.98
Interactions of anti-rheumatic drugs. Agents Actions Suppl (1977) 0.97
Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine. Ann Rheum Dis (1992) 0.97
Clinical rheumatology training of Australian medical students. A national survey of 1991 graduates. Med J Aust (1993) 0.97
Alterations in prednisolone disposition as a result of oral contraceptive use and dose. Br J Clin Pharmacol (1984) 0.97
Flurbiprofen-aspirin interaction: a double-blind crossover study. Curr Med Res Opin (1977) 0.96
Articular manifestations of acromegaly. Aust N Z J Med (1988) 0.96
Bacteriologic and histologic features in mice after intranasal inoculation of Brucella melitensis. Am J Vet Res (2001) 0.95
Non-steroidal anti-inflammatory drug induced upper gastrointestinal haemorrhage and bleeding. Med J Aust (1993) 0.95
Intraosseous lipoma. J Bone Joint Surg Br (1973) 0.95
Proceedings: Reading skills of children with generalized and focal epilepsy attending ordinary school. Electroencephalogr Clin Neurophysiol (1975) 0.95
A survey of outcome measurement procedures in routine rheumatology outpatient practice in Australia. J Rheumatol (1999) 0.95
The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in healthy subjects and patients with arthritis. Clin Exp Immunol (1990) 0.94
Comparative effectiveness of 5 analgesics in patients with rheumatoid arthritis and osteoarthritis. J Rheumatol (1983) 0.94
Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum (1998) 0.93
Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes. J Immunol (2000) 0.93
A comparison of plasma methylprednisolone concentrations following intra-articular injection in patients with rheumatoid arthritis and osteoarthritis. Aust N Z J Med (1983) 0.93
Current practice in antimalarial drug prescribing in rheumatoid arthritis. J Rheumatol (1986) 0.93
Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients. Br J Clin Pharmacol (1983) 0.93
Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium. Ann Rheum Dis (1998) 0.91
An analysis of the relationship between psychological morbidity and disease activity in rheumatoid arthritis. J Rheumatol (1988) 0.91
Migration of blood and synovial fluid neutrophils obtained from patients with rheumatoid arthritis. Clin Exp Immunol (1980) 0.90
A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. Arthritis Rheum (1999) 0.90
Living with osteoarthritis: patient expenditures, health status, and social impact. Arthritis Rheum (2001) 0.90
A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplant (1998) 0.89
Phenylbutazone: a clinico-pharmacological study in rheumatoid arthritis. Br J Clin Pharmacol (1975) 0.89
Musculoskeletal disability among elderly people in the community. Med J Aust (1998) 0.88
The ethnobotany of the Northern Cheyenne Indians of Montana. J Ethnopharmacol (1981) 0.88
Salivary antipyrine half-life: a useful measure of hepatic drug metabolism. Br J Clin Pharmacol (1976) 0.88
Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis. Br J Clin Pharmacol (1989) 0.88
A controlled evaluation of diagnostic criteria in the development of a rheumatology expert system. Br J Rheumatol (1989) 0.87
Costs and outcomes of total hip and knee joint replacement for rheumatoid arthritis. Clin Rheumatol (2008) 0.86
Measuring physicians' judgment--the use of clinical data by Australian rheumatologists. Aust N Z J Med (1985) 0.86
Monosodium urate crystals in asymptomatic knee joints. J Rheumatol (1983) 0.86
Biodistribution of 64Cu in inflamed rats following administration of two anti-inflammatory copper complexes. Agents Actions (1985) 0.86
Probenecid-clofibrate interaction. Clin Pharmacol Ther (1981) 0.86
Disease-modifying agents and immunosuppressive drugs in the elderly. Clin Rheum Dis (1986) 0.86
Early detection of aortic dilatation in ankylosing spondylitis using echocardiography. Aust N Z J Med (1982) 0.85
Protein binding of GP53,633: a basic non-steroidal anti-inflammatory drug. Biochem Pharmacol (1982) 0.85
A 5-year follow-up of a controlled trial of an arthritis education programme. Br J Rheumatol (1995) 0.85
Perception--a problem in the grading of sacro-iliac joint radiographs. Scand J Rheumatol (1984) 0.85
Immunoreactive gastrin and gestation. Am J Obstet Gynecol (1975) 0.85
The disposition of biphenylacetic acid following topical application. Eur J Clin Pharmacol (1988) 0.84
Biological effects of nonsteroidal anti-inflammatory drugs. Semin Arthritis Rheum (1975) 0.84
A destructive discovertebral lesion: septic discitis, ankylosing spondylitis, or rheumatoid arthritis? Clin Rheumatol (1989) 0.84
Osteoarthritis antirheumatic drug trials: effects of a standardized instructional videotape on the reliability of observer-dependent dependent outcome measures. Inflammopharmacology (1997) 0.83
Diflunisal disposition and hypouricemic response in osteoarthritis. Clin Pharmacol Ther (1983) 0.83
Closed Küntscher nailing: a clinical review after 20 years. Injury (1982) 0.83
Over the counter (OTC) oral remedies for arthritis and rheumatism: how effective are they? Inflammopharmacology (1999) 0.82
Composition and function of peripheral blood stem and progenitor cell harvests from patients with severe active rheumatoid arthritis. Br J Haematol (1998) 0.82
Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis. J Rheumatol (1984) 0.82
Metabolism of salicylate during chronic aspirin therapy. Br J Clin Pharmacol (1980) 0.82
Back pain in the workplace. Med J Aust (1987) 0.82